Ocugen (OCGN) Receives a Buy From Noble Financial
Buy Rating on Ocugen: Strong Financials and Promising Clinical Progress
Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH) and Ocugen (OCGN)
Noble Financial Maintains Ocugen(OCGN.US) With Buy Rating, Maintains Target Price $8
Ocugen Analyst Ratings
Buy Rating Affirmed for Ocugen on Strong Financials and Advancing Clinical Pipeline
Ocugen Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Ocugen (OCGN) and Moderna (MRNA)
Ocugen Analyst Ratings
Buy Rating Affirmed for Ocugen on Strong Clinical Progress and Financial Stability
Ocugen Analyst Ratings
Buy Rating Affirmed for Ocugen on Strong Clinical Progress and Positive Financial Outlook
Ocugen Analyst Ratings
Analyst Gives 'Buy' Rating to Ocugen Backed by Strong Financial Position and Promising Drug Pipeline
H.C. Wainwright Sticks to Their Buy Rating for Ocugen (OCGN)
Cantor Fitzgerald Maintains Overweight on Ocugen, Lowers Price Target to $2
Ocugen Analyst Ratings
Ocugen (OCGN) Gets a Buy From Noble Financial
Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), LAVA Therapeutics (LVTX) and Ocugen (OCGN)
HC Wainwright & Co. Reiterates Buy on Ocugen, Maintains $5 Price Target
No Data